Cancer Communications

Does the mind matter in Cancer?

Improving access to palliative care by enhancing primary care services in an upper middle-income country

Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC

Pembrolizumab shows notable antitumour activity for patients with high-risk non–muscle-invasive bladder cancer

Nivolumab and salvage nivolumab plus ipilimumab for aRCC

Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations

Cell-free utDNA may predict transurethral resection of bladder tumour pathology in non–muscle invasive bladder cancer

Choosing Wisely in haemato-medical oncology

Choosing Wisely campaigns in Africa

Lessons learned from Choosing Wisely campaigns in Africa